Literature DB >> 27816615

Nocturnal Urinary Disorders and Multiple Sclerosis: Clinical and Urodynamic Study of 309 Patients.

Elsa Mauruc1, Amandine Guinet-Lacoste2, Lætitia Falcou2, Philippe Manceau2, Delphine Verollet2, Frédérique Le Breton2, Gérard Amarenco2.   

Abstract

PURPOSE: The aim of this study was to describe nocturia with or without leakage in a population of patients with multiple sclerosis.
MATERIALS AND METHODS: This is a retrospective, single center study of 309 patients with multiple sclerosis who were followed at an experienced neurourology center between 2011 and 2013. All patients had daytime urinary symptoms associated with this disorder. Among the patients with nocturia 2 groups were defined, including those with isolated nocturia but without nocturnal urinary incontinence and patients with nocturia associated with nocturnal urinary incontinence. The control group comprised patients without nocturia. The clinical variables and urodynamic data studied were gender, age, EDSS (Expanded Disability Status Scale), the USP (Urinary Symptoms Profile) questionnaire overactive bladder score, bladder capacity, detrusor activity and volume at the first detrusor contraction.
RESULTS: Of our patients 53.3% had nocturia, including 35.7% with nocturnal urinary incontinence. The average ± SD USP overactive bladder score was statistically greater in patients with nocturia than in controls (9.14 ± 4.3 vs 5.1 ± 3.5, p = 8.21E-17). Mean maximum cystometric capacity was statistically higher in the control group than in patients with nocturia (380.17 ± 113.79 vs 313 ± 128.4 ml, p = 5.60E-6). A similar outcome was found for the first contraction (mean 232.58 ± 146.05 vs 181.14 ± 100.11 ml, p = 0.041).
CONCLUSION: Isolated nocturia or nocturnal urinary incontinence is a frequent problem encountered with multiple sclerosis. Our results suggest that an overactive detrusor is the main mechanism. Further studies are needed to verify the complications arising from nocturia.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cholinergic antagonists; multiple sclerosis; nocturia; overactive; sleep; urinary bladder

Mesh:

Year:  2016        PMID: 27816615     DOI: 10.1016/j.juro.2016.10.112

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Urodynamic findings in patients with nocturia and their associations with patient characteristics.

Authors:  Garson Chan; Liang G Qu; Johan Gani
Journal:  Can Urol Assoc J       Date:  2022-09       Impact factor: 2.052

2.  Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study.

Authors:  Yizhang Hu; Wenchao Lu; Borui Tang; Zhixia Zhao; Zhuoling An
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

3.  Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.

Authors:  Vivien Li; Jalesh N Panicker; Collette Haslam; Jeremy Chataway
Journal:  J Neurol       Date:  2020-07-16       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.